Synthetic antibodies easier to produce
For decades, lab-made antibodies have been used to support patients in fighting specific diseases. These treatments have become a cornerstone of cancer therapy and were among the first medical solutions developed to combat COVID-19. However, producing antibodies in the lab is costly and time-consuming. A research group from the University of Geneva (UNIGE) has developed…

